Browsing Tag
New York Stock Exchange
253 posts
CBIZ Q3 profit surges to $47m as Grant Thornton’s $55-a-share deal approaches key vote
CBIZ profit jumped 57% in Q3 as its $5 billion sale nears. See what earnings, cash flow and the $55 deal price mean for $CBZ investors.
Charles Schwab Q3 revenue reaches record $7.2bn as client assets grow
Charles Schwab reported record quarterly revenue and earnings as customers added $190.4 billion in net new assets, but a two-day share-price decline has sharpened attention on financing margins, lending growth and the sustainability of brokerage profitability.
Emergent’s Q2 adjusted EBITDA hit $96.5m, so what does its CFO successor inherit?
Emergent BioSolutions is moving to an interim finance chief as Richard Lindahl retires, adding leadership change to a transformation already reshaping costs, guidance and capital discipline.
ExxonMobil signals $4.5bn refining earnings boost as oil-price pressure hits upstream
ExxonMobil's preliminary third-quarter earnings factors reveal a major improvement in refining margins, contrasting with weaker crude oil realisations and substantial accounting timing effects ahead of its October 30 results.
Delta Air Lines cuts earnings outlook despite record revenue. Is its stock pricing in a longer fuel crisis?
Delta Air Lines shares are trading near $81 after the carrier reduced its 2026 earnings outlook amid a $6 billion increase in expected annual fuel costs. Strong premium travel demand and loyalty revenue provide support, but weakening free cash flow raises questions about whether the airline's valuation adequately reflects its financial risks.
Levi Strauss (NYSE: LEVI) raises outlook, but tariff boost complicates the signal
Levi Strauss lifted its FY2026 earnings outlook after Q3 adjusted EPS reached US$0.48, but tariff refunds contributed materially to the margin expansion while direct-to-consumer growth fell short of management's expectations.
HubSpot layoffs affect 660 employees as $3.68bn revenue outlook stays intact
HubSpot is eliminating nearly 660 jobs, or about 7% of its workforce, while reorganising product teams, reducing management layers and directing more resources toward AI-led customer outcomes. The restructuring comes despite double-digit revenue growth and leaves the company balancing a larger AI opportunity against demanding 2030 profitability targets and a stock still far below its 52-week high.
Transocean adds $1.1bn to firm backlog as Equinor and Shell contracts strengthen Norway position
Transocean adds about $1.1 billion to firm backlog through Equinor and Shell contracts. Find out what the awards could mean for RIG investors.
GSK agrees up to $750m Chimagen deal to deepen multiple myeloma pipeline
GSK is paying up to $750 million for a trispecific multiple myeloma asset, with early clinical data set to determine whether the deal creates value.
Reformation (NYSE: REF) lifts revenue 24% as adjusted EBITDA margin reaches 16.4%
Reformation delivered 24.1% second-quarter revenue growth and sharply higher profit in its first public earnings report, while a pre-IPO debt-funded shareholder dividend leaves investors with a more leveraged balance sheet.